Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
779.70
Change Change %
-14.30 -1.80%

Updated:20 Nov, 2018, 15:09 PM IST

BSE
780.05
Change Change %
-13.35 -1.68%

Updated:20 Nov, 2018, 15:15 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Citi
N/A
19-03-2015 Buy 1262.10 1945.00
N/A
Closed Custom
19-03-2016

Citi maintains buy on Aurobindo Pharma

Aurobindo Pharma is the top mid-cap pharma pick. Expect strong earnings per share growth for FY14-17. Company has been improving its balance sheet to drive re-rating.

Top